Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Cancer
|
May 15, 1989
Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells
D S Hoon, I Ando, G Sviland, et al.
International Journal of Cancer
|
April 15, 1976
Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects
H L Sulit, S H Golub, R F Irie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma
C T Kuo, P J Bostick, R F Irie, et al.
Journal of Immunological Methods
|
November 6, 1990
Murine monoclonal anti-idiotype antibody (alpha) as a probe to detect human monoclonal antibody bound to human tumor tissues
H Saito, D R Wen, S Yamamoto, et al.
The Journal of Investigative Dermatology
|
December 18, 1998
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy
T Okamoto, R F Irie, S Fujii, et al.
The Journal of Dermatology
|
February 1, 1995
Polysialogangliosides expressed by amelanotic melanoma: a possible explanation for the poor response to anti-monosialoganglioside antibody 202 in a patient with melanoma
S Hamanaka, T Ota, C Asagami, et al.
Cancer Research
|
November 1, 1993
Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers
D S Hoon, Y Wang, L Sze, et al.
Surgery
|
August 1, 1982
Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response
S S Ahn, R F Irie, T H Weisenburger, et al.
Seminars in Surgical Oncology
|
January 1, 1989
Active specific immunotherapy in malignant melanoma
D L Morton, L J Foshag, J A Nizze, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Cancer
|
May 15, 1989
Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells
D S Hoon, I Ando, G Sviland, et al.
International Journal of Cancer
|
April 15, 1976
Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects
H L Sulit, S H Golub, R F Irie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma
C T Kuo, P J Bostick, R F Irie, et al.
Journal of Immunological Methods
|
November 6, 1990
Murine monoclonal anti-idiotype antibody (alpha) as a probe to detect human monoclonal antibody bound to human tumor tissues
H Saito, D R Wen, S Yamamoto, et al.
The Journal of Investigative Dermatology
|
December 18, 1998
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy
T Okamoto, R F Irie, S Fujii, et al.
The Journal of Dermatology
|
February 1, 1995
Polysialogangliosides expressed by amelanotic melanoma: a possible explanation for the poor response to anti-monosialoganglioside antibody 202 in a patient with melanoma
S Hamanaka, T Ota, C Asagami, et al.
Cancer Research
|
November 1, 1993
Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers
D S Hoon, Y Wang, L Sze, et al.
Surgery
|
August 1, 1982
Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response
S S Ahn, R F Irie, T H Weisenburger, et al.
Seminars in Surgical Oncology
|
January 1, 1989
Active specific immunotherapy in malignant melanoma
D L Morton, L J Foshag, J A Nizze, et al.
Page
of 8